290 related articles for article (PubMed ID: 28806936)
1. Enhancement of hepatitis virus immunoassay outcome predictions in imbalanced routine pathology data by data balancing and feature selection before the application of support vector machines.
Richardson AM; Lidbury BA
BMC Med Inform Decis Mak; 2017 Aug; 17(1):121. PubMed ID: 28806936
[TBL] [Abstract][Full Text] [Related]
2. Infection status outcome, machine learning method and virus type interact to affect the optimised prediction of hepatitis virus immunoassay results from routine pathology laboratory assays in unbalanced data.
Richardson AM; Lidbury BA
BMC Bioinformatics; 2013 Jun; 14():206. PubMed ID: 23800244
[TBL] [Abstract][Full Text] [Related]
3. Hybrid model for precise hepatitis-C classification using improved random forest and SVM method.
Lilhore UK; Manoharan P; Sandhu JK; Simaiya S; Dalal S; Baqasah AM; Alsafyani M; Alroobaea R; Keshta I; Raahemifar K
Sci Rep; 2023 Aug; 13(1):12473. PubMed ID: 37528148
[TBL] [Abstract][Full Text] [Related]
4. Predicting the presence of hepatitis B virus surface antigen in Chinese patients by pathology data mining.
Shang G; Richardson A; Gahan ME; Easteal S; Ohms S; Lidbury BA
J Med Virol; 2013 Aug; 85(8):1334-9. PubMed ID: 23765772
[TBL] [Abstract][Full Text] [Related]
5. The development of a machine learning algorithm for early detection of viral hepatitis B infection in Nigerian patients.
Ajuwon BI; Richardson A; Roper K; Sheel M; Audu R; Salako BL; Bojuwoye MO; Katibi IA; Lidbury BA
Sci Rep; 2023 Feb; 13(1):3244. PubMed ID: 36829040
[TBL] [Abstract][Full Text] [Related]
6. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
7. Joint modeling strategy for using electronic medical records data to build machine learning models: an example of intracerebral hemorrhage.
Tang J; Wang X; Wan H; Lin C; Shao Z; Chang Y; Wang H; Wu Y; Zhang T; Du Y
BMC Med Inform Decis Mak; 2022 Oct; 22(1):278. PubMed ID: 36284327
[TBL] [Abstract][Full Text] [Related]
8. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
10. Stroke Prediction with Machine Learning Methods among Older Chinese.
Wu Y; Fang Y
Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32178250
[TBL] [Abstract][Full Text] [Related]
11. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
12. Comparative assay of Hepatitis B and C virus infection markers by different assay kits.
Shimbo S; Zhang ZW; Qu JB; Watanabe T; Makatsuka H; Matsuda-Inoguchi N; Higashikawa K; Ikeda M
Biomed Environ Sci; 2000 Sep; 13(3):198-204. PubMed ID: 11198221
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Approaches for the Prediction of Hepatitis B and C Seropositivity.
Harabor V; Mogos R; Nechita A; Adam AM; Adam G; Melinte-Popescu AS; Melinte-Popescu M; Stuparu-Cretu M; Vasilache IA; Mihalceanu E; Carauleanu A; Bivoleanu A; Harabor A
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767747
[TBL] [Abstract][Full Text] [Related]
14. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
15. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
[TBL] [Abstract][Full Text] [Related]
16. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
[TBL] [Abstract][Full Text] [Related]
17. Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C.
Ryu JH; Kwon M; Moon JD; Hwang MW; Lee JM; Park KH; Yun SJ; Bae HJ; Choi A; Lee H; Jung B; Jeong J; Han K; Kim Y; Oh EJ
Ann Lab Med; 2018 Nov; 38(6):578-584. PubMed ID: 30027702
[TBL] [Abstract][Full Text] [Related]
18. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
[TBL] [Abstract][Full Text] [Related]
19. Seminal quality prediction using data mining methods.
Sahoo AJ; Kumar Y
Technol Health Care; 2014; 22(4):531-45. PubMed ID: 24898862
[TBL] [Abstract][Full Text] [Related]
20. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
